6/15/2021 7:37:24 AM
Cytokinetics Announces Completion Of Patient Enrollment In METEORIC-HF
5/19/2021 7:39:39 AM
Cytokinetics, ALS Association Renew Partnership To Fight Against Amyotrophic Lateral Sclerosis
5/17/2021 8:25:58 AM
Cytokinetics Presents Data From Secondary Analysis Of GALACTIC-HF
4/12/2021 7:37:39 AM
Cytokinetics Presents Preclinical Data For CK-3773274 At American Chemical Society Spring 2021 Virtual Meeting
2/18/2021 7:44:03 AM
Cytokinetics Names Muna Bhanji To Board
1/13/2021 7:33:48 AM
Cytokinetics Says First Patient Dosed In Cohort 2 Of REDWOOD-HCM; Earns $2.5 Mln Milestone
1/11/2021 7:46:55 AM
Cytokinetics Says FDA Has Granted Orphan Drug Designation To CK-3773274
12/23/2020 7:35:41 AM
Cytokinetics Regains European Rights To Omecamtiv Mecarbil
12/1/2020 7:43:47 AM
Cytokinetics To Present Results From GALACTIC-HF At Global Cardiovascular Clinical Trialists Forum
11/23/2020 7:36:27 AM
Amgen Provides Notice To Cytokinetics Of Termination Of Its Collaboration For Omecamtiv Mecarbil And AMG 594
10/8/2020 8:36:09 AM
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF Trial Did Not Meet Secondary Endpoint
10/2/2020 8:00:52 AM
Cytokinetics Publishes Manuscript Detailing Baseline Characteristics Of GALACTIC-HF In European Journal
9/24/2020 7:45:26 AM
Cytokinetics Announces Call For Proposals For Third Annual Communications Fellowship Program